{"schema_version":"1","generated_at":"2026-11-09T12:29:13.972Z","data_as_of":null,"url":"https://www.findmykol.com/kol/boyu-hu","json_url":"https://www.findmykol.com/kol/boyu-hu/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"boyu-hu","name":"Boyu Hu","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1033478144"},"summary":"Boyu Hu is an Oncology physician. ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07638722","title":"Testing Mosunetuzumab Alone, With Zanubrutinib, or With Polatuzumab Vedotin for Treating Marginal Zone Lymphoma That Came Back or Didn't Get Better With Treatment","phase":"PHASE2","status":"NOT_YET_RECRUITING","role":"Overall official","sponsor":"SWOG Cancer Research Network","source_url":"https://clinicaltrials.gov/study/NCT07638722","trial_url":"https://www.findmykol.com/trial/NCT07638722"},{"nct":"NCT05405309","title":"RP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic Leukemia","phase":"PHASE1/PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"University of Utah","source_url":"https://clinicaltrials.gov/study/NCT05405309","trial_url":"https://www.findmykol.com/trial/NCT05405309"},{"nct":"NCT03843294","title":"Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma","phase":"PHASE1","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"Catherine Bollard","source_url":"https://clinicaltrials.gov/study/NCT03843294","trial_url":"https://www.findmykol.com/trial/NCT03843294"}],"source":"trials"},"payments":{"company_count":19,"program_years":{"first":2021,"last":null},"rows_total":48,"shown":3,"withheld":45,"rows":[{"payer":"AstraZeneca","program_year":2025,"amount_usd":421770.85,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1033478144"},{"payer":"Genentech, Inc.","program_year":2025,"amount_usd":225000,"payment_count":15,"source_url":"https://openpaymentsdata.cms.gov/search?query=1033478144"},{"payer":"Incyte","program_year":2025,"amount_usd":99640.9,"payment_count":6,"source_url":"https://openpaymentsdata.cms.gov/search?query=1033478144"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1033478144","source":"payments"},"prescribing":{"data_year":2024,"areas_total":6,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":43.8,"classes_total":2,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":37.2,"drugs":[{"name":"Brukinsa","share_pct":68.3},{"name":"Calquence","share_pct":23.4},{"name":"Jaypirca","share_pct":8.3}],"max_beneficiaries":null},{"class":"BCL-2 Inhibitor","setting":"prescribed","share_pct":6.7,"drugs":[{"name":"Venclexta","share_pct":100}],"max_beneficiaries":null}]},{"area":"Dermatology","share_pct":31.3,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":31.3,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":24}]},{"area":"Metabolism & gastrointestinal","share_pct":11,"classes_total":3,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":4.9,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":13},{"class":"Corticosteroid","setting":"prescribed","share_pct":3.3,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"contact":{"address_1":"1515 HOLCOMBE BLVD","address_2":"UNIT #463","city":"Houston","state":"TX","zip":"77030","phone":"713-792-0077","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1033478144","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-10-19","provider_certified":"2021-10-19","collected_at":"2026-11-06T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}